Comparative effectiveness of an angiotensin receptor blocker, olmesartan medoxomil, in older hypertensive patients

The efficacy and safety of olmesartan medoxomil (OM) vs active control (AC) monotherapy among elderly patients aged 60‐79 years (N = 4487) was evaluated by meta‐analysis (25 studies). In all patients, change from baseline to end point in blood pressure (BP) was significantly greater with OM vs AC (−...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Clin Hypertens (Greenwich)
Asıl Yazarlar: Redon, Josep, Weber, Michael A., Reimitz, Paul‐Egbert, Wang, Ji‐Guang
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley and Sons Inc. 2018
Konular:
Hypertension Therapy
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8031060/
https://ncbi.nlm.nih.gov/pubmed/29462508
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jch.13183
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller